Education
About Us
Working with TipRanks
Follow Us
BIOTON S.A. (DE:7U5)
FRANKFURT:7U5
7U5 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.64 - €1.15
Previous CloseN/A
Volume0.00
Average Volume (3M)17.00
Market Cap
€90.49M
Enterprise Value€394.61M
Total Cash (Recent Filing)€2.74M
Total Debt (Recent Filing)€49.78M
Price to Earnings (P/E)―
Beta0.23
Next Earnings
Oct 30, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding85,864,200
10 Day Avg. Volume0
30 Day Avg. Volume17
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€1.05Price Target Upside0.96% Upside
Rating ConsensusHold
Number of Analyst Covering0
7U5 FAQ
What was BIOTON S.A.’s price range in the past 12 months?
BIOTON S.A. lowest stock price was €0.64 and its highest was €1.15 in the past 12 months.
What is BIOTON S.A.’s market cap?
BIOTON S.A.’s market cap is €90.49M.
When is BIOTON S.A.’s upcoming earnings report date?
BIOTON S.A.’s upcoming earnings report date is Oct 30, 2025 which is in 30 days.
How were BIOTON S.A.’s earnings last quarter?
BIOTON S.A. released its earnings results on Sep 17, 2025. The company reported €0.009 earnings per share for the quarter, beating the consensus estimate of N/A by €0.009.
Is BIOTON S.A. overvalued?
According to Wall Street analysts BIOTON S.A.’s price is currently Undervalued.
Does BIOTON S.A. pay dividends?
BIOTON S.A. does not currently pay dividends.
What is BIOTON S.A.’s EPS estimate?
BIOTON S.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BIOTON S.A. have?
BIOTON S.A. has 85,864,200 shares outstanding.
What happened to BIOTON S.A.’s price movement after its last earnings report?
BIOTON S.A. reported an EPS of €0.009 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.02%.
Which hedge fund is a major shareholder of BIOTON S.A.?
Currently, no hedge funds are holding shares in DE:7U5
Company Description
BIOTON S.A.
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceuticals, pharmaceutical preparations, pharmaceutical substances, medications, and other pharmaceutical products in Poland, China, Thailand, Vietnam, Libya, Argentina, Ukraine, Malta, Yemen, and the Russian Federation. The company offers recombinant human and classic insulin; oral anti-diabetic medication products; dietary supplements; strips for measuring sugar in blood, as well as OTC preparation for diabetics; diabetics drugs insulin vials and cartridges, including Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. It engages in advertising, advisory, and company management activities. The company was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
Technical Analysis
Options Prices
Currently, No data available
---